TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2a, Randomized, Double-blind, Placebo-Controlled, Parallel-Arm, Multicenter Study to Evaluate the Efficacy and Safety of CAT-354, a Recombinant Human Monoclonal Antibody Directed Against Interleukin-13 (IL-13), on Asthma Control in Adults With Uncontrolled, Moderate-to-severe, Persistent Asthma
Brief Summary: This is a Phase 2a, randomized, double-blind, placebo-controlled, parallel-arm study to evaluate the efficacy and safety of 3 subcutaneous (SC) treatment regimens of CAT-354 in adult subjects with uncontrolled, moderate-to-severe, persistent asthma.


Options:
A: Arm Label: Omalizumab; Type: EXPERIMENTAL; Interventions: Drug: Omalizumab, Drug: Fluticasone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Fluticasone | Intervention Type: DRUG; Name: Omalizumab; Assigned to Arm(s): Omalizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Fluticasone; Assigned to Arm(s): Omalizumab, Placebo
B: Arm Label: Alair; Type: EXPERIMENTAL; Interventions: Device: Alair System | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Alair System | Intervention Type: DEVICE; Name: Alair System; Assigned to Arm(s): Alair | Intervention Type: DEVICE; Name: Alair System; Assigned to Arm(s): Sham
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: CAT-354 150 mg; Type: EXPERIMENTAL; Interventions: Biological: CAT-354 150 mg | Arm Label: CAT-354 300 mg; Type: EXPERIMENTAL; Interventions: Biological: CAT-354 300 mg | Arm Label: CAT-354 600 mg; Type: EXPERIMENTAL; Interventions: Biological: CAT-354 600 mg | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: CAT-354 150 mg; Assigned to Arm(s): CAT-354 150 mg | Intervention Type: BIOLOGICAL; Name: CAT-354 300 mg; Assigned to Arm(s): CAT-354 300 mg | Intervention Type: BIOLOGICAL; Name: CAT-354 600 mg; Assigned to Arm(s): CAT-354 600 mg
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: lebrikizumab (MILR1444A) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: lebrikizumab (MILR1444A); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The EVOLVO study is designed to compare the remote defibrillator management to the current standard of care, to assess its ability to treat and triage patients more effectively.


Options:
A: Arm Label: Remote Arm; Type: N/A; Interventions: Device: The Medtronic CareLink system (Minneapolis, MN, USA). | Arm Label: Implantable defibrillator patients; Type: N/A; Interventions: Device: The Medtronic CareLink system (Minneapolis, MN, USA). | Intervention Type: DEVICE; Name: The Medtronic CareLink system (Minneapolis, MN, USA).; Assigned to Arm(s): Implantable defibrillator patients, Remote Arm
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Telemedicine | Arm Label: 2; Type: NO_INTERVENTION; Interventions: Behavioral: Telemedicine | Intervention Type: BEHAVIORAL; Name: Telemedicine; Assigned to Arm(s): 1, 2
C: Arm Label: Home Monitoring; Type: ACTIVE_COMPARATOR; Interventions: Other: Home Monitoring | Arm Label: In-Office Conventional Follow-up; Type: OTHER; Interventions: Other: In-Office Conventional Follow-up | Intervention Type: OTHER; Name: Home Monitoring; Assigned to Arm(s): Home Monitoring | Intervention Type: OTHER; Name: In-Office Conventional Follow-up; Assigned to Arm(s): In-Office Conventional Follow-up
D: Intervention Type: BEHAVIORAL; Name: Internet-based Dyspnea Self-Management Program; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face Dyspnea Self-Management Program; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Three Modalities of Continuous Positive Pressure Airway Treatment for Obstructive Sleep Apnea Syndrome
Brief Summary: The purpose of this study is to compare the treatment adherence and effects in three modalities of Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: BiPap auto with Fi Flex | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard CPAP | Intervention Type: DEVICE; Name: BiPap auto with Fi Flex; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Standard CPAP; Assigned to Arm(s): 2
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: constant CPAP devices | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: automatic CPAP devices | Intervention Type: DEVICE; Name: constant CPAP devices; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: automatic CPAP devices; Assigned to Arm(s): 2
C: Intervention Type: DEVICE; Name: AutoCPAP; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: FixCPAP; Assigned to Arm(s): N/A
D: Arm Label: C-flex; Type: ACTIVE_COMPARATOR; Interventions: Device: CPAP (REMstar (Respironics)) | Arm Label: A-flex; Type: ACTIVE_COMPARATOR; Interventions: Device: CPAP (REMstar (Respironics)) | Arm Label: Auto-CPAP; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: CPAP (REMstar (Respironics)); Assigned to Arm(s): A-flex, C-flex

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Brief Summary: This trial tests the feasibility of enrolling 60 extremely preterm infants in a randomized, double-blinded study of blood pressure management within 12 months. Eligible infants will receive an infusion drug (dopamine or a dextrose placebo) and a syringe drug (hydrocortisone or a normal saline placebo).

Enrolled infants will be randomized to receive one of the following drug pairs:

* dopamine and hydrocortisone
* dopamine and normal saline
* dextrose and hydrocortisone
* dextrose and normal saline.

In addition to the intervention above, the NRN is conducting a 6-month time-limited prospective observational study of all infants born at an NRN center between 23 and 26 weeks gestational age. All clinical decisions made for these babies will be at the discretion of the attending neonatologist/infant care team according to standard practice at each institution. Data on blood pressure management in the first 24 postnatal hours collected for each infant.


Options:
A: Arm Label: Dopamine and hydrocortisone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dopamine, Drug: Hydrocortisone | Arm Label: Dopamine and placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dopamine, Drug: Syringe Placebo | Arm Label: Placebo and hydrocortisone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydrocortisone, Drug: Infusion Placebo | Arm Label: Placebo and Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Infusion Placebo, Drug: Syringe Placebo | Intervention Type: DRUG; Name: Dopamine; Assigned to Arm(s): Dopamine and hydrocortisone, Dopamine and placebo | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): Dopamine and hydrocortisone, Placebo and hydrocortisone | Intervention Type: DRUG; Name: Infusion Placebo; Assigned to Arm(s): Placebo and Placebo, Placebo and hydrocortisone | Intervention Type: DRUG; Name: Syringe Placebo; Assigned to Arm(s): Dopamine and placebo, Placebo and Placebo
B: Arm Label: 1: hydrocortisone; Type: EXPERIMENTAL; Interventions: Drug: hydrocortisone | Arm Label: 2: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: hydrocortisone; Assigned to Arm(s): 1: hydrocortisone | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2: Placebo
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Hydrocortisone | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Hydrocortisone; Type: EXPERIMENTAL; Interventions: Drug: Hydrocortisone | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): Hydrocortisone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Benefits of Lower Limb Electrostimulation Training on Muscular Parameters and Minute Ventilation During Exercise in Severe and Deconditioned COPD Patients.
Brief Summary: This study was designed to test the following hypothesis:

The benefit of electrostimulation training will be greater than sham stimulation training in term of muscle strength and mass (muscle hypertrophy), exercise tolerance, reduction of ventilation during exercise and quality of life in COPD patients


Options:
A: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity counseling | Intervention Type: BEHAVIORAL; Name: physical activity counseling; Assigned to Arm(s): Counseling | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care
B: Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Device: Electrostimulation | Arm Label: Sham ES; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham stimulation | Intervention Type: DEVICE; Name: Electrostimulation; Assigned to Arm(s): ES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): Sham ES
C: Arm Label: Pedometer-based activity promotion; Type: EXPERIMENTAL; Interventions: Behavioral: Pedometer-based activity promotion, Other: Pulmonary rehabilitation (Standard care) | Arm Label: Short patient education and exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short patient education and exercise, Other: Pulmonary rehabilitation (Standard care) | Intervention Type: BEHAVIORAL; Name: Pedometer-based activity promotion; Assigned to Arm(s): Pedometer-based activity promotion | Intervention Type: BEHAVIORAL; Name: Short patient education and exercise; Assigned to Arm(s): Short patient education and exercise | Intervention Type: OTHER; Name: Pulmonary rehabilitation (Standard care); Assigned to Arm(s): Pedometer-based activity promotion, Short patient education and exercise
D: Arm Label: Home-base Pulm Rehab w/ Health Coaching; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home-base Pulmonary Rehab with Health Coaching | Arm Label: Control/Wait; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home-base Pulmonary Rehab with Health Coaching | Intervention Type: BEHAVIORAL; Name: Home-base Pulmonary Rehab with Health Coaching; Assigned to Arm(s): Control/Wait, Home-base Pulm Rehab w/ Health Coaching

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Benefits of Lower Limb Electrostimulation Training on Muscular Parameters and Minute Ventilation During Exercise in Severe and Deconditioned COPD Patients.
Brief Summary: This study was designed to test the following hypothesis:

The benefit of electrostimulation training will be greater than sham stimulation training in term of muscle strength and mass (muscle hypertrophy), exercise tolerance, reduction of ventilation during exercise and quality of life in COPD patients


Options:
A: Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Device: Electrostimulation | Arm Label: Sham ES; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham stimulation | Intervention Type: DEVICE; Name: Electrostimulation; Assigned to Arm(s): ES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): Sham ES
B: Arm Label: NMES; Type: EXPERIMENTAL; Interventions: Device: Neuromuscular Electrostimulation (NMES) CareStim Muscle Stimulation Device (Care Rehab; McLean, VA) | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Sham | Intervention Type: DEVICE; Name: Neuromuscular Electrostimulation (NMES) CareStim Muscle Stimulation Device (Care Rehab; McLean, VA); Assigned to Arm(s): NMES | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): Sham
C: Arm Label: Neuromuscular Electrical Stimulation (NMES); Type: EXPERIMENTAL; Interventions: Device: Neuromuscular Electrical Stimulation (NMES) | Arm Label: Standard Rehabilitation Protocol; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Rehabilitation Protocol | Intervention Type: DEVICE; Name: Neuromuscular Electrical Stimulation (NMES); Assigned to Arm(s): Neuromuscular Electrical Stimulation (NMES) | Intervention Type: OTHER; Name: Standard Rehabilitation Protocol; Assigned to Arm(s): Standard Rehabilitation Protocol
D: Arm Label: EMS group; Type: EXPERIMENTAL; Interventions: Procedure: EMS | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: EMS; Assigned to Arm(s): EMS group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Benefits of Lower Limb Electrostimulation Training on Muscular Parameters and Minute Ventilation During Exercise in Severe and Deconditioned COPD Patients.
Brief Summary: This study was designed to test the following hypothesis:

The benefit of electrostimulation training will be greater than sham stimulation training in term of muscle strength and mass (muscle hypertrophy), exercise tolerance, reduction of ventilation during exercise and quality of life in COPD patients


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: COPD Self-Management Plan | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: COPD Self-Management Plan; Assigned to Arm(s): Intervention Group
B: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Breathlessness Support Service; Type: EXPERIMENTAL; Interventions: Other: Breathlessness Support Service | Intervention Type: OTHER; Name: Breathlessness Support Service; Assigned to Arm(s): Breathlessness Support Service
C: Arm Label: sPATH; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): sPATH
D: Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Device: Electrostimulation | Arm Label: Sham ES; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham stimulation | Intervention Type: DEVICE; Name: Electrostimulation; Assigned to Arm(s): ES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): Sham ES

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Benefits of Lower Limb Electrostimulation Training on Muscular Parameters and Minute Ventilation During Exercise in Severe and Deconditioned COPD Patients.
Brief Summary: This study was designed to test the following hypothesis:

The benefit of electrostimulation training will be greater than sham stimulation training in term of muscle strength and mass (muscle hypertrophy), exercise tolerance, reduction of ventilation during exercise and quality of life in COPD patients


Options:
A: Arm Label: One single arm group; Type: EXPERIMENTAL; Interventions: Device: FES-cycling, Device: Classic cycloergometer | Intervention Type: DEVICE; Name: FES-cycling; Assigned to Arm(s): One single arm group | Intervention Type: DEVICE; Name: Classic cycloergometer; Assigned to Arm(s): One single arm group
B: Intervention Type: DEVICE; Name: Neuromuscular Electrical stimulator (Cefar rehab 4 pro); Assigned to Arm(s): N/A
C: Arm Label: NMES group; Type: EXPERIMENTAL; Interventions: Other: Neuromuscular electrical stimulation, Other: Endurance training, Other: Quadriceps strength training | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Other: Endurance training, Other: Quadriceps strength training | Intervention Type: OTHER; Name: Neuromuscular electrical stimulation; Assigned to Arm(s): NMES group | Intervention Type: OTHER; Name: Endurance training; Assigned to Arm(s): Control group, NMES group | Intervention Type: OTHER; Name: Quadriceps strength training; Assigned to Arm(s): Control group, NMES group
D: Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Device: Electrostimulation | Arm Label: Sham ES; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham stimulation | Intervention Type: DEVICE; Name: Electrostimulation; Assigned to Arm(s): ES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): Sham ES

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial.
Brief Summary: The primary objective of the study is to demonstrate the efficacy of 60% ethanol lock solution in preventing major catheter related infections in critically ill patients.


Options:
A: Arm Label: ethanol; Type: EXPERIMENTAL; Interventions: Other: Ethanol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Ethanol | Intervention Type: OTHER; Name: Ethanol; Assigned to Arm(s): ethanol, placebo
B: Intervention Type: DRUG; Name: Cefazolin IV; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Linezolid IV; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Vancomycin (IV); Assigned to Arm(s): N/A
C: Arm Label: ClearGuard HD end cap; Type: ACTIVE_COMPARATOR; Interventions: Device: ClearGuard HD end cap | Arm Label: Standard hemodialysis end cap; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: ClearGuard HD end cap; Assigned to Arm(s): ClearGuard HD end cap
D: Arm Label: NAC/Tigecycline/Heparin combination lock solution; Type: EXPERIMENTAL; Interventions: Drug: NAC/Tigecycline/Heparin combination lock solution | Arm Label: Standard anticoagulant (heparin or citrate); Type: PLACEBO_COMPARATOR; Interventions: Drug: Standard anticoagulant (Heparin or Citrate) | Intervention Type: DRUG; Name: NAC/Tigecycline/Heparin combination lock solution; Assigned to Arm(s): NAC/Tigecycline/Heparin combination lock solution | Intervention Type: DRUG; Name: Standard anticoagulant (Heparin or Citrate); Assigned to Arm(s): Standard anticoagulant (heparin or citrate)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Perioperative Supplemental Oxygen and the Risk of Surgical Site Infection
Brief Summary: This is a study to see whether increasing the oxygen concentration during and after a cesarean section decreases the infection rate.


Options:
A: Arm Label: 70% Nitrous Oxide; Type: OTHER; Interventions: Other: Nitrous Oxide | Arm Label: No Nitrous Oxide; Type: OTHER; Interventions: Other: No Nitrous Oxide | Intervention Type: OTHER; Name: Nitrous Oxide; Assigned to Arm(s): 70% Nitrous Oxide | Intervention Type: OTHER; Name: No Nitrous Oxide; Assigned to Arm(s): No Nitrous Oxide
B: Arm Label: 80% oxygen group; Type: N/A; Interventions: Drug: Oxygen | Arm Label: 30% oxygen group; Type: N/A; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): 30% oxygen group, 80% oxygen group
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: standard operating management | Intervention Type: PROCEDURE; Name: standard operating management; Assigned to Arm(s): 2
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen by mask | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen by mask | Intervention Type: OTHER; Name: Oxygen by mask; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Oxygen by mask; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double Blind Randomized Controlled Trial in School Going Children, to Evaluate the Impact of a Multiple Micronutrient Fortified Nutritional Powder on Physical Performance Measures
Brief Summary: The purpose of this study is to evaluate the effect of nutritional supplement on physical performance measures of apparently healthy school going children in India.


Options:
A: Arm Label: fortified extruded rice; Type: EXPERIMENTAL; Interventions: Dietary Supplement: fortified extruded rice | Intervention Type: DIETARY_SUPPLEMENT; Name: fortified extruded rice; Assigned to Arm(s): fortified extruded rice
B: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Nutritional supplement; Type: EXPERIMENTAL; Interventions: Other: Nutritional supplement | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: OTHER; Name: Nutritional supplement; Assigned to Arm(s): Nutritional supplement | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: triple fortified extruded rice; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Triple fortified extruded tice (Fe, Zn and vitamin A) | Arm Label: regular meal; Type: OTHER; Interventions: Dietary Supplement: Triple fortified extruded tice (Fe, Zn and vitamin A) | Intervention Type: DIETARY_SUPPLEMENT; Name: Triple fortified extruded tice (Fe, Zn and vitamin A); Assigned to Arm(s): regular meal, triple fortified extruded rice
D: Arm Label: Non-Fortified Control Product; Type: PLACEBO_COMPARATOR; Interventions: Other: Non-Fortified Control Product | Arm Label: Micronutrient Fortified Test Product; Type: ACTIVE_COMPARATOR; Interventions: Other: Micronutrient Fortified Test Product | Intervention Type: OTHER; Name: Non-Fortified Control Product; Assigned to Arm(s): Non-Fortified Control Product | Intervention Type: OTHER; Name: Micronutrient Fortified Test Product; Assigned to Arm(s): Micronutrient Fortified Test Product

Answer: B